/PRNewswire/ Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address.
/PRNewswire/ Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address.
John Lacey: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.
/PRNewswire/ Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address.
BioLineRx Ltd. (NASDAQ:NASDAQ:BLRX) Q3 2022 Earnings Conference Call November 15, 2022, 10:00 AM ET Company Participants John Lacey - IR Philip Serlin - Chief Executive Officer Mali Zeevi -.